We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CPAY:NYSECorpay, Inc. Analysis

Data as of 2026-03-10 - not real-time

$329.08

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Corpay trades at $329, below its 20‑day SMA of $335 and well under the DCF‑derived fair value of $764, indicating ample upside. The company posted 20.7% YoY revenue growth to $4.53 B and delivered an operating margin of 57%, underscoring a high‑margin business model. Profitability is further highlighted by a 23.6% net margin and a ROE of 29%, placing it ahead of many software peers. Valuation metrics are attractive, with a trailing P/E of 22 versus an industry average of 37 and a forward P/E of 11, suggesting earnings acceleration is already priced in. Analysts collectively rate CPAY a “buy” with a median price target of $382, implying roughly a 16% upside from current levels. Technical signals show a bullish trend, the price sits above the 50‑day SMA of $326 and the RSI at 49.8 signals no overbought pressure. However, MACD remains bearish and volatility is elevated at 57% over the past 30 days, reflecting short‑term uncertainty.
The balance sheet carries a high debt load (total debt $10.3 B, debt‑to‑equity >240), though the firm generates robust free cash flow of $1.89 B and holds $2.42 B in cash. This leverage amplifies financial risk, especially if interest rates rise, but strong cash generation provides a cushion. The company’s transition from fuel cards to diversified corporate payments has been rewarded, with Q4 2025 reporting 21% revenue and 13% EPS growth. The sector—technology‑focused software infrastructure—faces moderate regulatory scrutiny but benefits from ongoing digital‑payment adoption. No dividend is paid, aligning with a growth‑oriented capital allocation strategy. Overall, the combination of solid fundamentals, attractive valuation, and a clear growth narrative supports a bullish stance, while the high beta and debt warrant caution. Investors should consider positioning near support around $308 and target the resistance zone near $362, aligning with the consensus upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • price near support at $308
  • bearish MACD histogram
  • high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 20% revenue growth and expanding margins
  • analyst consensus buy with 16% upside target
  • strong free cash flow offsetting debt load

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • secular shift to digital corporate payments
  • high ROE and sustainable profitability
  • significant undervaluation relative to industry multiples

Key Metrics & Analysis

Financial Health

Revenue Growth20.70%
Profit Margin23.63%
P/E Ratio21.9
ROE29.07%
ROA6.04%
Debt/Equity243.35
P/B Ratio5.8
Op. Cash Flow$1.5B
Free Cash Flow$1.9B
Industry P/E36.8

Technical Analysis

TrendBullish
RSI49.8
Support$307.77
Resistance$361.99
MA 20$335.12
MA 50$325.75
MA 200$313.12
MACDBearish
VolumeStable
Fear & Greed Index76.91

Valuation

Fair Value$764.34
Target Price$384.71
Upside/Downside16.91%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.47
Volatility57.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.